Finland· FI-REL-REL7536
Biopen 800
A phenoxymethylpenicillin product, registered in Finland by Pharmacal Oy Ab. The same ATC class is registered in 16 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Phenoxymethylpenicillin is registered in 16 of 19 countries.
Countries holding a registration under ATC J01CE02 (phenoxymethylpenicillin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 9 of them publish a price we can compare per daily dose
Phenoxymethylpenicillin · ATC J01CE02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Manufacturer
- Pharmacal Oy Ab
- Country
- Finland (FI)
- ATC code
- J01CE02
- ATC class
- Phenoxymethylpenicillin
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
43 interactions on record for phenoxymethylpenicillin.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Phenoxymethylpenicillin · interactions on record
43 records
- 3 severe
- 19 moderate
- 2 minor
- 19 info
Most severe, free to view
- MethotrexateL01BA01severe
- MethotrexateL04AX03severe
- MethotrexatM01CX01severe
- Sodium picosulfateA06AB08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01CE02
Phenoxymethylpenicillin, as other registers publish it.
- FinlandAcipen SolutabYamanouchi Europe B.V.
- FinlandAcipen SolutabYamanouchi Europe B.V.
- FinlandAcipen SolutabYamanouchi Europe B.V.
- FinlandAcipen SolutabYamanouchi Europe B.V.
- FinlandAcipen SolutabYamanouchi Europe B.V.
- NetherlandsAcipen-V 250 mg, harde capsulesACE Pharmaceuticals B.V.
- NorwayActacillinTeva B.V.
- NorwayActacillinTeva B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b4137729-38dc-4d25-b4a7-43632469cb22 GET /v1/drugs/b4137729-38dc-4d25-b4a7-43632469cb22?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "2",
"form": "tabletti",
"route": null,
"ddd_unit": "g",
"strength": "800000 IU",
"atc_label": "fenoksimetyylipenisilliini",
"ma_number": "7730",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL7536",
"authorised_at": "1979-02-07"
}See everything about phenoxymethylpenicillin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.